- Home
- OMH vs AYTU Comparison
OMH vs AYTU Comparison
Compare OMH & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- AYTU
- Stock Information
- Founded
- OMH 2015
- AYTU N/A
- Country
- OMH Singapore
- AYTU United States
- Employees
- OMH N/A
- AYTU N/A
- Industry
- OMH Real Estate
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- AYTU Health Care
- Exchange
- OMH Nasdaq
- AYTU Nasdaq
- Market Cap
- OMH 9.1M
- AYTU 10.5M
- IPO Year
- OMH 2023
- AYTU N/A
- Fundamental
- Price
- OMH $0.51
- AYTU $1.78
- Analyst Decision
- OMH Strong Buy
- AYTU
- Analyst Count
- OMH 1
- AYTU 0
- Target Price
- OMH $1.50
- AYTU N/A
- AVG Volume (30 Days)
- OMH 254.3K
- AYTU 36.1K
- Earning Date
- OMH 01-10-2025
- AYTU 02-12-2025
- Dividend Yield
- OMH N/A
- AYTU N/A
- EPS Growth
- OMH N/A
- AYTU N/A
- EPS
- OMH N/A
- AYTU N/A
- Revenue
- OMH $5,390,607.00
- AYTU $79,759,000.00
- Revenue This Year
- OMH $101.90
- AYTU N/A
- Revenue Next Year
- OMH $38.34
- AYTU N/A
- P/E Ratio
- OMH N/A
- AYTU N/A
- Revenue Growth
- OMH 25.77
- AYTU N/A
- 52 Week Low
- OMH $0.32
- AYTU $1.30
- 52 Week High
- OMH $6.00
- AYTU $3.45
- Technical
- Relative Strength Index (RSI)
- OMH 69.54
- AYTU 63.61
- Support Level
- OMH $0.37
- AYTU $1.43
- Resistance Level
- OMH $0.43
- AYTU $1.60
- Average True Range (ATR)
- OMH 0.03
- AYTU 0.10
- MACD
- OMH 0.01
- AYTU 0.05
- Stochastic Oscillator
- OMH 100.00
- AYTU 98.96
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.